Levosert, Intrauterines Wirkstofffreisetzungssystem

7680654440013 CH-65444 Intrauterines Wirkstofffreisetzungssystem

Associated product:

LEVOSERT SIU 20 mcg/24h
Levosert, Intrauterines Wirkstofffreisetzungssystem
Levosert, Intrauterines Wirkstofffreisetzungssystem
Levosert, Intrauterines Wirkstofffreisetzungssystem
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Stück
Galenic form
Intrauterines Wirkstofffreisetzungssystem
Galenic group
Unknown

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
17/05/2024
Summary of Product Characteristics
Français
17/05/2024
Summary of Product Characteristics
Italien
17/05/2024
Patient information leaflet
Allemand
10/04/2024
Patient information leaflet
Français
10/04/2024
Patient information leaflet
Italien
10/04/2024

Detailed composition

Substance Quantity Type Category
(N/A)
52.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FCOSM

Reimbursement information

Public price
CHF 145.85
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/11/2019

Authorization holder

Gedeon Richter (Schweiz) AG

1202 Genève

Authorization information

Swissmedic authorization number
65444
Drug name
Levosert, Intrauterines Wirkstofffreisetzungssystem
Galenic form
IUWFS
ATC Code
G02BA03
Authorization status
Z
Dispensing category
B
First authorization
24/08/2015
Authorization expiration date
31/12/9999
IT Number
09.02.2.
Domain
Human medicine
Field of application
Intrauterine Kontrazeption und Idiopathische Hypermenorrhoe

Package details

Description (FR)
LEVOSERT SIU 20 mcg/24h
Description (DE)
LEVOSERT IUP 20 mcg/24h
Market launch
24/08/2015
Narcotic (BTM)
No